Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Clinical Medicine & Research|December 7, 2007
The contribution of luteinizing hormone to Alzheimer disease pathogenesisKate M Webber, George Perry, Mark A Smith, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|January 29, 2008
Evidence for the role of luteinizing hormone in Alzheimer diseaseKate M Webber, Gemma Casadesus, Richard L Bowen, et al.Acta Neurobiologiae Experimentalis|June 12, 2004
Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotectionKate M Webber, Richard Bowen, Gemma Casadesus, et al.Alzheimer Disease and Associated Disorders|June 9, 2005
Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesisKate M Webber, Gemma Casadesus, George Perry, et al.Molecular and Cellular Endocrinology|October 21, 2006
Gonadotropins: a cohesive gender-based etiology of Alzheimer diseaseKate M Webber, Gemma Casadesus, Craig S Atwood, et al.Current Drug Targets. CNS and Neurological Disorders|September 24, 2004
Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's diseaseGemma Casadesus, Xiongwei Zhu, Craig S Atwood, et al.Journal of Neuroscience Research|January 7, 2005
Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's diseaseKate M Webber, Mark A Smith, Hyoung-gon Lee, et al.Biochimica Et Biophysica Acta|March 1, 2006
Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic miceGemma Casadesus, Kate M Webber, Craig S Atwood, et al.Free Radical Research|January 23, 2009
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's diseaseSandra L Siedlak, Gemma Casadesus, Kate M Webber, et al.Advances in Clinical Chemistry|April 24, 2008
Menopause, estrogen, and gonadotropins in Alzheimer's diseaseGemma Casadesus, Raj K Rolston, Kate M Webber, et al.Pageof 2